Trial Profile
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Darunavir; Maraviroc; Raltegravir; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 11 Dec 2015 New trial record